Literature DB >> 2335837

A balloon-expandable intravascular stent for obliterating experimental aortic dissection.

M S Trent1, V Parsonnet, R Shoenfeld, B J Brener, D E Eisenbud, A S Novick, A Y Campbell, M Ferrara-Ryan, A Villanueva.   

Abstract

Acute aortic dissection is a life-threatening condition. Aggressive hypotensive drug therapy is the initial treatment of choice, although emergent surgical intervention is often warranted. We evaluated the efficacy of a balloon-expandable intravascular stent for the internal obliteration of aortic dissection. It is a flexible, continuous, complex coil cut to the length needed at the time of insertion. It can be positioned in curved vessels, including the aortic arch. The stent was inserted in the thoracic and abdominal aorta of 12 dogs (group I). Six weeks after implantation the dogs underwent angiography and the stents were explanted for light and scanning electron microscopy. There were no instances of stent migration or change in configuration. The aortas did not rupture. All branch vessels remained patent. Light and scanning electron microscopy illustrated neointimal incorporation into the vascular wall except at orifices. Thoracic dissections were created surgically in an additional 24 mongrel dogs. Twelve dogs received stents immediately after creation of the dissection (group II). All 12 dissections were obliterated. Twelve dogs were allowed to recover after creation of the dissection to observe the natural history of that lesion (group III). Within 1 week, in group III, there were three deaths because of aortic rupture; eight dissections persisted, and one resealed spontaneously. Stents were placed in the eight persistent dissections. All eight dissections were obliterated. In both groups, after 6 weeks of stent placement, aortography was repeated, and stents were explanted for light and scanning electron microscopy. There were no instances of rupture. All branch vessels remained patent with no evidence of thrombosis. We conclude that because of its unique characteristics, the stent effectively obliterates the false lumen of experimental acute aortic dissections without occlusing side branches, damaging the aorta, or inducing thrombosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2335837

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  6 in total

1.  Percutaneous balloon-expandable stents for sealing of acute aortic dissection.

Authors:  A Ramírez; J Suárez de Lezo; M Pan; J Segura; M Romero; D Pavlovic; A Medina
Journal:  Tex Heart Inst J       Date:  2000

Review 2.  Endovascular surgery for peripheral arterial occlusive disease. A critical review.

Authors:  S S Ahn; D Eton; W S Moore
Journal:  Ann Surg       Date:  1992-07       Impact factor: 12.969

Review 3.  TEVAR for type B aortic dissection in Japan.

Authors:  Akihiko Usui
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-12-10

4.  Chronic aortoiliac dissection treated by self-expanding stent placement.

Authors:  D Vorwerk; R W Günther; G Wendt; B Messmer
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Jan-Feb       Impact factor: 2.740

Review 5.  Management of adults with coarctation of aorta.

Authors:  Pradyumna Agasthi; Sai Harika Pujari; Andrew Tseng; Joseph N Graziano; Francois Marcotte; David Majdalany; Farouk Mookadam; Donald J Hagler; Reza Arsanjani
Journal:  World J Cardiol       Date:  2020-05-26

6.  Endovascular Treatment of Coarctation of the Aorta with a Self-Expanding Endoprosthesis: How I Do It Using the Braile Dominus® Coarctation Aorta Device.

Authors:  Rodrigo Petersen Saadi; Eduardo Keller Saadi; Ana Paula Tagliari; Marina Petersen Saadi
Journal:  Braz J Cardiovasc Surg       Date:  2021-12-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.